After achieving a landmark settlement, in which the negligent defendants have agreed to fund immunotherapy for a claimant who has developed cancer, Michael Rawlinson QC examines the dilemma of the prospect and effect of immunotherapy in a recent blog post.
The full blog post can be found here.
Court of Protection Masterclass: Hosted by Clarion
Virtual seminar: 'P, Undue Influence & Statutory Wills'
Corporate Insolvency and Governance Act 2020
© Copyright 2020 Kings Chambers. All rights reserved.
Coronavirus (CoVID-19) Public Health England (PHE) recommendations – please view our important guidelines.
Continue using site